Your browser doesn't support javascript.
loading
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018.
Finlay, David B; Nguyen, Thuy; Gamage, Thomas F; Chen, Shuli; Barrus, Daniel G; Patel, Purvi R; Thomas, Brian F; Wiley, Jenny L; Zhang, Yanan; Glass, Michelle.
Afiliación
  • Finlay DB; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • Nguyen T; RTI International, Research Triangle Park, North Carolina, USA.
  • Gamage TF; RTI International, Research Triangle Park, North Carolina, USA.
  • Chen S; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • Barrus DG; RTI International, Research Triangle Park, North Carolina, USA.
  • Patel PR; RTI International, Research Triangle Park, North Carolina, USA.
  • Thomas BF; RTI International, Research Triangle Park, North Carolina, USA.
  • Wiley JL; RTI International, Research Triangle Park, North Carolina, USA.
  • Zhang Y; RTI International, Research Triangle Park, North Carolina, USA.
  • Glass M; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Pharmacol Res Perspect ; 10(1): e00901, 2022 02.
Article en En | MEDLINE | ID: mdl-35041297
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carbazoles / Receptor Cannabinoide CB1 / Agonistas de Receptores de Cannabinoides / Naftalenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Res Perspect Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carbazoles / Receptor Cannabinoide CB1 / Agonistas de Receptores de Cannabinoides / Naftalenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Res Perspect Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Estados Unidos